| First Author | Barclay KM | Year | 2024 |
| Journal | Immunity | Volume | 57 |
| Issue | 6 | Pages | 1394-1412.e8 |
| PubMed ID | 38821054 | Mgi Jnum | J:349784 |
| Mgi Id | MGI:7658707 | Doi | 10.1016/j.immuni.2024.05.005 |
| Citation | Barclay KM, et al. (2024) An inducible genetic tool to track and manipulate specific microglial states reveals their plasticity and roles in remyelination. Immunity 57(6):1394-1412.e8 |
| abstractText | Recent single-cell RNA sequencing studies have revealed distinct microglial states in development and disease. These include proliferative-region-associated microglia (PAMs) in developing white matter and disease-associated microglia (DAMs) prevalent in various neurodegenerative conditions. PAMs and DAMs share a similar core gene signature. However, the extent of the dynamism and plasticity of these microglial states, as well as their functional significance, remains elusive, partly due to the lack of specific tools. Here, we generated an inducible Cre driver line, Clec7a-CreER(T2), that targets PAMs and DAMs in the brain parenchyma. Utilizing this tool, we profiled labeled cells during development and in several disease models, uncovering convergence and context-dependent differences in PAM and DAM gene expression. Through long-term tracking, we demonstrated microglial state plasticity. Lastly, we specifically depleted DAMs in demyelination, revealing their roles in disease recovery. Together, we provide a versatile genetic tool to characterize microglial states in CNS development and disease. |
